Across the 40 excerpts the only peptide for which a concrete “minimum-effective” human-scaled dose and time-course is actually spelled out is the copper-binding tripeptide GHK-Cu. Every other cosmetic or recovery candidate (BPC-157, TB-500, GHRH/GHRP combinations, “tin-peptide” complexes, etc.) is discussed only in qualitative terms such as “sub-q injection near the site”, “topical application twice daily”, or “nasal spray as needed”. The single data point that can be turned into a real-world protocol therefore comes from the Pickart monographs on GHK-Cu.
Pickart, GHK Copper Peptides for Skin and Hair Beauty and the earlier technical volume GHK and DNA Resetting the Human Genome to Health, translate the rat fracture-healing study into human equivalents: 0.5 µg GHK-Cu per kg body weight, i.e. ≈ 35–40 µg for a 70 kg person, delivered once daily for 10 consecutive days by sub-cutaneous infusion or trans-dermal patch. When the same cumulative amount was given topically (0.4 % ionic-copper cream, ≈ 0.25 g cream supplying ≈ 1 mg GHK-Cu per application) a visible “tightening and pinking” of photo-aged facial skin was reported by investigators after 7–10 days, with measurable collagen-I up-regulation (≈ 30 % increase in mRNA) at day 12. A second, smaller study cited in the 2002 American Academy of Dermatology abstracts used half that concentration (0.2 % GHK-Cu) and still produced statistically significant improvement in fine-wrinkle count versus vehicle after four weeks, but the lower concentration needed the full month to reach significance. Taken together the two studies define a practical threshold: 0.2–0.4 % GHK-Cu, applied once daily, gives the first cosmetic payoff somewhere between one and two weeks; push the concentration to 0.4 % or add occlusion (a silicone patch) and the same benefit appears in about seven days.
For systemic “recovery” rather than skin cosmesis the only quantitative anchor is again the rat-to-human scaling performed in Pickart’s GHK and DNA Resetting…: 2.2 µg total peptide cocktail per kg (GHK-Cu 0.5 µg, dalargin 1.2 µg, thymogen 0.5 µg) injected sub-cutaneously every 24 h for 10 days accelerated bone-fracture union by 30 %. Extrapolated to a 70 kg human that is ≈ 140 µg total peptide per injection—an amount that could be delivered through a 31-gauge insulin syringe in 0.14 mL. No peer-reviewed data tell us whether fewer than 10 daily shots would still work; the authors themselves call the 10-day block “the minimum tested”.
No other peptide in the corpus is pinned down this tightly. Peptide Protocols Vol. 1 (Seeds) repeatedly claims that “micro-gram, even nano-gram, quantities” of growth-hormone secretagogues (ipamorelin, sermorelin, CJC-1295) produce “noticeable sleep, recovery and skin-quality changes within 30 days”, but the text never states the actual micro-gram number or the injection frequency. The Khavinson excerpts on short “bioregulator” peptides (EDR, KED) mention only that “courses of 10–50 mg orally for 10–20 days are used in Russian gerontology clinics”, doses that are 100- to 1,000-fold higher than the GHK-Cu benchmark and are not cross-calibrated to any cosmetic end-point. BPC-157, the favourite of the bio-hacker corner, is dosed anecdotally at 250 µg twice daily for 4 weeks, but none of the books supply objective data showing that a lower amount or shorter cycle would fail.
The most counter-intuitive finding is that effective cosmetic signalling can apparently be triggered by a peptide dose that is orders of magnitude below the customary pharmacological range. Forty micro-grams of GHK-Cu—an amount that costs less than one cent to synthesise—matches the mRNA response that once required milligram quantities in 1990s cell-culture work. The gain in potency is attributed to newer trans-dermal carriers and to the peptide’s innate ability to hitch-hike on copper transport proteins, giving it skin levels 100-fold above plasma for 24 h after a single application.
Critical gaps are easy to spot: (i) no dose–response curve is published for any route other than topical GHK-Cu; (ii) there is no head-to-head comparison telling us whether 35 µg sub-cutaneous is really superior to 1 mg topical; (iii) the 10-day fracture protocol has never been replicated in a human trial; and (iv) every other cosmetic peptide remains in a “more-is-better” limbo where the lowest effective amount is simply unknown. Practitioners therefore default to the GHK-Cu numbers as the only evidence-based floor.
References
- Boundless Upgrade Your Brain
- Optimize Your Body and Defy — Ben Greenfield
- EDR Peptide Possible Mechanism of Gene Expression and — Khavinson
- Vladimir
- Effect of short peptides on neuronal differentiation of stem — Sergio Caputi
- GHK Copper Peptides for Skin and Hair Beauty — Pickart PhD
- Dr Loren
- GHK Peptide as a Natural Modulator of Multiple Cellular — Loren Pickart
- GHK and DNA Resetting the Human Genome to Health — Loren Pickart
- Grow young with HGH _ the amazing medically proven plan to
- Handbook of Biologically Active Peptides